SOSEI GROUP
Sosei Group Corporation is an international biopharmaceutical company originating from Japan that discovers and develops innovative biopharmaceuticals for the treatment of Alzheimer's disease, schizophrenia, cancer, migraine, addiction, metabolic disease, and other indications. By utilizing their platform technologies - GPCR structure-based drug design platform technology, peptide platform technologies and nanotechnology - they have established a product pipeline with first/best in class potential. Through development and commercialization partnerships they have already delivered three medicines to the market (two COPD bronchodilators and an emergency contraceptive), which generate significant and stable revenue streams that enable further growth.
SOSEI GROUP
Social Links:
Industry:
Biopharma Biotechnology Medical
Founded:
1990-06-01
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.sosei.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
265.03 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS 1and1 Adobe Dreamweaver Sophos
Similar Organizations
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2015-02-22 | Heptares Therapeutics | Heptares Therapeutics acquired by Sosei Group | 400 M USD |
| 2005-07-19 | Arakis Limited | Arakis Limited acquired by Sosei Group | 106.5 M GBP |
Investors List
COVID-19 Therapeutics Accelerator
COVID-19 Therapeutics Accelerator investment in Grant - Sosei Group
JAFCO
JAFCO investment in Post-IPO Equity - Sosei Group
Scottish Equity Partners
Scottish Equity Partners investment in Post-IPO Equity - Sosei Group
Resona Capital
Resona Capital investment in Series B - Sosei Group
Yasuda Enterprise Development
Yasuda Enterprise Development investment in Series B - Sosei Group
Mitsui Global Investment
Mitsui Global Investment investment in Series B - Sosei Group
JAFCO
JAFCO investment in Series B - Sosei Group
Japan Asia Investment
Japan Asia Investment investment in Series B - Sosei Group
Nomura Holdings
Nomura Holdings investment in Series B - Sosei Group
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2017-05-03 | MiNA Therapeutics | Sosei Group investment in Corporate Round - MiNA Therapeutics | 35 M GBP |
| 2016-11-11 | JITSUBO | Sosei Group investment in Venture Round - JITSUBO | 2.5 B JPY |
Official Site Inspections
http://www.sosei.com
- Host name: s20998836.onlinehome-server.info
- IP address: 217.160.183.146
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Sosei Group"
Sosei Group - Crunchbase Company Profile & Funding
Sosei Group Corporation is an international biopharmaceutical company originating from Japan that discovers and develops innovative biopharmaceuticals for the treatment of Alzheimer's …See details»
Sosei Group Company Profile | Management and Employees List
Sosei Group Profile and History. We are an international biopharmaceutical group focused on the discovery and early development of new medicines originating from our proprietary GPCR …See details»
SOSEI GROUP CORPORATION overview - Companies House
UK establishments for SOSEI GROUP CORPORATION (FC024112) More for SOSEI GROUP CORPORATION (FC024112) Overseas company address 2-1 Kojimachi, Chiyoda-Ku, Tokyo, …See details»
Nxera Pharma is the New Name for Sosei Group - Japan …
Apr 1, 2024 Tokyo, Japan and Cambridge, UK, 1 April 2024 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company; TSE 4565) – formerly known as Sosei Group or Sosei Heptares – is pleased …See details»
Sosei Group - Funding, Financials, Valuation & Investors
Feb 22, 2015 Sosei is a Japanese biopharmaceutical company that develops and commercializes innovative drugs. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
Sosei Group - Overview, News & Similar companies - ZoomInfo
Sosei Group contact info: Phone number: +81 352103290 Website: www.sosei.com What does Sosei Group do? Sosei Group Corp is a company that operates in the Pharmaceuticals …See details»
Sosei Group - Overview, News & Similar companies - ZoomInfo
Who is Sosei Group. We are an international biopharmaceutical group focused on the discovery and early development of new medicines originating from our proprietary GP CR-targeted …See details»
Sosei Group Corp. Company Profile | StatInvestor
Sosei Group Corp. engages in the discovery, design, and development of medicines targeting G protein-coupled receptors (GPCRs). Its proprietary StaR (Stabilised Receptor) technology and …See details»
Sosei (Group) - Life-Sciences-Europe.com
Sosei Heptares is a fully integrated biopharmaceutical company focused on bringing life-changing medicines based on world-class science to patients globally.See details»
Sosei Group Corp Company Profile & Data: stocks, market cap
Jul 1, 2024 Sosei Group Corporation develops biopharmaceutical products worldwide. Its marketed products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of …See details»
Sosei Group Corp - Company Profile - Market Research Reports ...
Sosei Group Corp (Sosei) is a biopharmaceutical company that develops and commercializes drugs. Its medical products include Ultibro, Seebri, Enerzair, Breezhaler, and Oravi. The …See details»
Sosei Heptares Confirms Re-election of its Board and Executive ...
Mar 27, 2024 Sosei Heptares is a fully integrated biopharmaceutical company focused on bringing life-changing medicines based on world-class science to patients globally. Our vision …See details»
Sosei Co. Ltd. - Tokio, Japan - bionity.com
Sosei Group Corporation is a leading international biopharmaceutical company with significant expertise in product discovery and development. It has established a reduced risk business …See details»
Sosei Group - Products, Competitors, Financials, Employees ...
Sosei Group is a company that focuses on the design and development of GPCR medicine, operating in the pharmaceutical industry. The company's main offerings include the …See details»
Sosei Group Corporation Proposes Changes to its Leadership …
Organization and support the discovery and development of new medicines for patients living with high unmet medical need. Importantly, Dr. Barnes willprioritize the ... Various risks may cause …See details»
Nxera Pharma Co., Ltd. - Drug pipelines, Patents, Clinical trials
Nov 1, 2024 Sosei Group Corp. is a pharmaceutical company that specializes in discovering, designing, and developing medications that target G protein-coupled receptors (GPCRs). ...See details»
Sosei Heptares Operational Highlights and Consolidated Results …
Feb 13, 2024 Tokyo, Japan and Cambridge, UK, 13 February 2024 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565) provides an update on operational activities …See details»
Sosei - Crunchbase Company Profile & Funding
Sosei is located in Fukushima-shi, Fukushima, Japan. Who are Sosei 's competitors? Alternatives and possible competitors to Sosei may include Japan Amenity Life Association , Koyukai …See details»
Sosei Co. Ltd. Company Profile- Outlook, Business Segments, …
6 SOSEI CO. LTD. - HISTORY 7 SOSEI CO. LTD. - BUSINESS OPERATION STRUCTURE 7.1 Business Overview 7.2 Operations by Segments 8 SOSEI CO. LTD. - PRODUCTS AND …See details»
SOSEI - VentureRadar
SOSEI specializes in regenerative solutions for agriculture, focusing on the intricate ecosystem within healthy soil. The company leverages the natural balance of soil ecosystems to promote …See details»